Page 128 - GPD-3-4
P. 128

Gene & Protein in Disease                                       PIVKA-II in differential diagnosis of AFP-NHCC



               an  immunologic  inflammatory  state  and  head  and  neck   optimal sequence and timing.  AJR Am J Roentgenol.
               cancer growth in a humanized murine model. Head Neck.   2023;220(6):900.
               2022;44(6):1324-1334.
                                                                  doi: 10.2214/ajr.22.28846
               doi: 10.1002/hed.27028
                                                               29.  Fotiadis N, De Paepe KN, Bonne L, et al. Comparison of
            19.  Qiao W, Leng F, Liu T, et al. Prognostic value of prealbumin   a coaxial versus non-coaxial liver biopsy technique in an
               in liver cancer: A systematic review and meta-analysis. Nutr   oncological  setting:  Diagnostic  yield,  complications  and
               Cancer. 2020;72(6):909-916.                        seeding risk. Eur Radiol. 2020;30(12):6702-6708.
               doi: 10.1080/01635581.2019.1661501                 doi: 10.1007/s00330-020-07038-7
            20.  Chiang HC, Lin MY, Lin FC, et al. Transferrin and prealbumin   30.  Yin L, Chen L, Qi Z, et al. Gene expression-based immune
               identify esophageal cancer patients with malnutrition and   infiltration analyses of liver cancer and their associations
               poor prognosis in patients with normal albuminemia:   with survival outcomes. Cancer Genet. 2021;254-255:75-81.
               A cohort study. Nutr Cancer. 2022;74(10):3546-3555.
                                                                  doi: 10.1016/j.cancergen.2021.02.001
               doi: 10.1080/01635581.2022.2079687
                                                               31.  Yu H, He J, Liu W,  et  al. The transcriptional coactivator,
            21.  Casadei Gardini A, Foschi FG, Conti F,  et al. Immune   ALL -fused gene from chromosome 9, simultaneously
                                                                      1
               inflammation indicators and ALBI score to predict liver   sustains hypoxia tolerance and metabolic advantages in liver
               cancer in HCV-patients treated with direct-acting antivirals.   cancer. Hepatology. 2021;74(4):1952-1970.
               Dig Liver Dis. 2019;51(5):681-688.
                                                                  doi: 10.1002/hep.31870
               doi: 10.1016/j.dld.2018.09.016
                                                               32.  Nazzal M, Sur S, Steele R, et al. Establishment of a patient-
            22.  Moon G, Noh H, Cho IJ, Lee JI, Han A. Prediction of late   derived  xenograft  tumor  from  hepatitis  C-Associated
               recurrence in patients with breast cancer: Elevated Neutrophil   liver cancer and evaluation of imatinib treatment efficacy.
               to Lymphocyte Ratio (NLR) at 5 years after diagnosis and late   Hepatology. 2020;72(2):379-388.
               recurrence. Breast Cancer. 2020;27(1):54-61.
                                                                  doi: 10.1002/hep.31298
               doi: 10.1007/s12282-019-00994-z
                                                               33.  Abouzed TK, Althobaiti F, Omran AF,  et al. The
            23.  Qian L, Li C, Luo Y, Meng S. Research progress of AFP in   chemoprevention of spirulina platensis and garlic against
               the diagnosis and therapy of hepatocellular carcinoma.   diethylnitrosamine induced liver cancer in rats via
               Sheng Wu  Gong Cheng Xue Bao = Chin  J Biotechnol.   amelioration  of  inflammatory  cytokines  expression  and
               2021;37(9):3042-3060.                              oxidative stress. Toxicol Res (Camb). 2022;11(1):22-31.
               doi: 10.13345/j.cjb.210235                         doi: 10.1093/toxres/tfab118
            24.  Wang T, Zhang KH. New blood biomarkers for the diagnosis   34.  Sugimoto A, Yoshizawa A, Yoshida A, et al. Retroperitoneal
               of AFP-negative hepatocellular carcinoma.  Front Oncol.   malignant extra-gastrointestinal neuroectodermal tumor
               2020;10:1316.                                      with EWSR1:CREM fusion and IL-6-related systemic
               doi: 10.3389/fonc.2020.01316                       inflammatory symptoms: A  case report.  Virchows Arch.
                                                                  2023;482(5):911-915.
            25.  Yahoo N, Dudek M, Knolle P, Heikenwälder M. Role of
               immune responses in the development of NAFLD-associated      doi: 10.1007/s00428-022-03442-0
               liver cancer and prospects for therapeutic modulation.   35.  McFarland DC, Doherty M, Atkinson TM,  et al. Cancer-
               J Hepatol. 2023;79(2):538-551.                     related inflammation and depressive symptoms: Systematic
               doi: 10.1016/j.jhep.2023.02.033                    review and meta-analysis. Cancer. 2022;128(13):2504-2519.
            26.  Yu C, Sun C. Diagnostic value of multislice spiral computed      doi: 10.1002/cncr.34193
               tomography combined with serum AFP, TSGF, and GP73   36.  Pratt  HG,  Steinberger  KJ,  Mihalik  NE,  et al.  Macrophage
               assay in the diagnosis of primary liver cancer. Evid Based   and neutrophil interactions in the pancreatic tumor
               Complement Alternat Med. 2022;2022:6581127.        microenvironment drive the pathogenesis of pancreatic
               doi: 10.1155/2022/6581127                          cancer. Cancers (Basel). 2021;14(1):194.
            27.  Zhou J, Chen L, Chen L, Zhang Y, Yuan Y. Emerging role of      doi: 10.3390/cancers14010194
               nanoparticles in the diagnostic imaging of gastrointestinal   37.  Schauer T, Mazzoni AS, Henriksson A,  et al. Exercise
               cancer. Semin Cancer Biol. 2022;86(Pt 2):580-594.
                                                                  intensity and markers of inflammation during and after
               doi: 10.1016/j.semcancer.2022.04.009               (neo-) adjuvant cancer treatment.  Endocr Relat  Cancer.
                                                                  2021;28(3):191-201.
            28.  Yu H. Editorial comment: Thermal ablation plus systemic
               chemotherapy in colorectal cancer liver oligometastases-the      doi: 10.1530/erc-20-0507


            Volume 3 Issue 4 (2024)                         9                               doi: 10.36922/gpd.4269
   123   124   125   126   127   128   129   130   131   132   133